Abstract: Healthcare object (HCO) discriminator systems and methods are presented. Systems can obtain a digital representation of a scene via a sensor interface. An HCO discriminator platform analyzes the digital representation to discriminate objects within the scene as being associated with a type of HCO or as being unrelated to a type of HCO. Once the HCO recognition platform determines that a type of HCO is relevant, it instantiates an actual HCO. The HCO can be routed to one or more destinations based on routing rules generated from a template or based on the manner in which the objects in the scene were discriminated.

Abstract: A fluid disinfecting system includes a straight fluid directing conduit and a light source disposed on a side of the fluid directing conduit. The light source is operative to emit ultraviolet light into the fluid directing conduit, such that one or more cross sections of said fluid directing conduit are saturated with ultraviolet light. Any fluid passing through the fluid directing conduit is necessarily exposed to the ultraviolet light.

Abstract: The technology detects undesirable data packets. Data packets are received from multiple sources at one or more packet switches in a data communications network. The one or more packet switches route the data packets to one or more intended destination computing nodes and also transmit a copy of all the data packets received in the data communications network to a network capture device. The network capture device processes the data packets, detects financial data packets, and transmits the detected financial data packets for analysis by a risk exposure computer system that performs automatic financial risk analysis based on the detected financial data packets.

Abstract: A method of controlling an exhaust valve arrangement of an internal combustion engine is provided. The exhaust valve arrangement is operable to direct combusted exhaust gas out from a combustion chamber of the internal combustion engine. The exhaust valve arrangement comprises a first exhaust valve and a second exhaust valve. The method includes determining a pressure level in the combustion chamber during compression release braking, comparing the pressure level with a predetermined threshold pressure; and controlling the exhaust valve arrangement to control either a single one, or both, of the first and second exhaust valves to be arranged in an open position during compression release braking in response to the pressure level being below or above the predetermined threshold pressure.

Abstract: A vehicle hood assembly can include a vehicle body structure and a hood moveable with respect to the vehicle body structure from a closed state to an opened state. A first linkage can connect the hood to the vehicle body structure and include a first linkage aperture extending therethrough. A second linkage can connect the hood to the vehicle body structure and include a second linkage aperture extending therethrough. A central axis of the first linkage aperture can be coaxial with a central axis of the second linkage aperture if the hood is in the opened state. A key structure can be provided and configured to simultaneously fit into both the second linkage aperture and the first linkage aperture if the hood is in the opened state.

Abstract: A method for jump-starting a hydrogen fuel cell-powered aircraft is disclosed. The method accesses a fuel cell stack containing latent oxygen therein. Accesses a hydrogen fuel source and provides hydrogen from the hydrogen fuel source into the fuel cell stack causing the hydrogen to mix with the latent oxygen in the fuel cell stack and generate a voltage. The voltage is then provided to a component of the hydrogen fuel cell-powered aircraft such that additional oxygen is introduced to the fuel stack.

Abstract: Disclosed are platforms for communicating among one or more otherwise independent systems involved in controlling functions of buildings or other sites having switchable optical devices deployed therein. Such independent systems include a window control system and one or more other independent systems such as systems that control residential home products (e.g., thermostats, smoke alarms, etc.), HVAC systems, security systems, lighting control systems, and the like. Together the systems control and/or monitor multiple features and/or products, including switchable windows and other infrastructure of a site, which may be a commercial, residential, or public site.

Abstract: Described herein are methods for producing and identifying characteristic (“crescent shaped”) regions indicative of an atherectomy plaque within a vessel, and systems and devices adapted to take advantage of this characteristic region.

Abstract: Provided herein are immunogenic compositions containing recombinant viruses capable of inducing protection in poultry against both Marek's disease virus (MDV) and Newcastle disease virus (NDV). Such viruses incorporate nucleic acids for expressing at least one MDV antigen, such as glycoprotein B, and antigenic portions thereof, in a recombinant NDV genome.

Abstract: Disclosed is incorporating an IQ stream into a test signal for a receiver in motion, configuring a path for the motion of the receiver during simulation, a period of the simulation, a transmitter constellation to emulate, and a path of at least one IQ stream transmitter. Also generating signals emulating the transmitter constellation and conditioning the stream to be merged with the signals, using distance and relative motion between receiver and transmitter to determine delay and Doppler shift between transmitter and receiver in motion, scheduling sampling of the signal, including interpolation among samples of the stream, based on delay and Doppler shift, and synthesizing a conditioned stream from the interpolation between the samples, taking into account signal level of the stream, in addition to delay and shift, and merging the conditioned signal with the signals emulating the transmitter constellation and supplying the merged signals to the receiver during the test.

Abstract: The present disclosure relates to fluoride ion batteries and structures of metal based electrode materials for various fluoride ion batteries. The structures of the metal based electrode materials comprise one or more shells or interfaces, enabling the electrodes to operate at room temperature with a liquid electrolyte.

Abstract: Disclosed herein are compounds useful for treating obstructive lung diseases. The compounds are TAS2Rs agonists and may further be used to treat disorders and conditions implicated by TAS2R. In some instances the disclosed compounds can be used to treat asthma.

Abstract: Provided is a support structure and a method for manufacture thereof. The support structure, in one aspect, includes first and second expanded metal structural pillars positioned within the ground by a distance (d1), the first and second expanded metal structural pillars comprising a metal that has expanded in response to hydrolysis. In at least one other aspect, the support structure includes one or more beams spanning the first and second expanded metal structural pillars.

Abstract: An assembly for controlling waste material during a hybrid subtractive and additive manufacturing process is disclosed, including a machining tool held in a holder, a shroud disposed around the machining tool, and one or more ports configured to create a negative pressure within the shroud. A method of constraining waste material during a hybrid subtractive and additive manufacturing process of a part includes adding an amount of material to a part being additively manufactured, transforming the amount of material that was added, manipulating a tool to machine a portion of the part being additively manufactured and generating a waste material, sealing a portion of the tool and covering a portion of the part with a shroud, and applying a negative pressure to create an airflow to prevent the waste material from exiting the shroud.

Abstract: The present invention features compositions and methods for amplifying a target oligonucleotide in a sample, including detection of the target oligonucleotide in real time.

Abstract: A system includes a main power source configured to provide power to at least one pulsed electrical load. The system also includes a propulsion converter configured to drive a propulsion motor. The system further includes a controllable-field induction electrical machine coupled to the at least one pulsed load. The controllable-field induction electrical machine is configured to suppress one or more propulsion current harmonics generated by the propulsion converter that affect the at least one pulsed load.

Abstract: A method and apparatus for an indoor horticultural system that utilizes a wired network to control lighting. The wired interface is used to relay both analog and digital intensity control information, whereby an analog signal is used to control the intensity of all LED arrays in each lighting fixture during a first mode of operation and a digital signal is used to control the intensity of each individual LED array in each lighting fixture in a second mode of operation. Both the analog and digital signals utilize the same physical interface.

Abstract: An electrophoretic display includes an electrophoretic medium having a non-polar fluid and two sets of charged pigment particles dispersed in the non-polar fluid and movable through the non-polar fluid under influence of an electric field. The two sets of charged pigment particles have different optical characteristics from each other. The display also includes a light-transmissive electrode on one side of the electrophoretic medium, a rear electrode on an opposite side of the electrophoretic medium, and a dielectric layer having a dielectric constant greater than 5 between the electrophoretic medium and the light-transmissive electrode or between the electrophoretic medium and the rear electrode configured to reduce electrode electrochemical degradation and buildup of remnant voltages in the display.

Abstract: The invention relates to a pharmaceutical composition comprising a combination of a compound of formula (I) or a pharmaceutically acceptable salt thereof, and at least one second agent selected from the group consisting of signal transduction pathway inhibitors, tumour immunotherapeutics, agents inhibiting the BCL2 family of proteins, agents inhibiting Mcl-1, proteasome Inhibitors, poly (ADP-ribose) polymerase (PARP) Inhibitors, aromatase inhibitors, conventional cytotoxic agents or a miscellaneous agent selected from abiraterone, ARN-509 and MYC inhibitors.